持続的腎代替療法市場：製品、モダリティ、年齢層、適応症、エンドユーザー別-2025-2030年世界予測

持続的腎代替療法市場は、2023年に142億8,000万米ドルと評価され、2024年には154億9,000万米ドルに達すると予測され、CAGR 8.55%で成長し、2030年には253億7,000万米ドルに達すると予測されています。

持続的腎代替療法（CRRT）は、主に集中治療室で急性腎不全の患者をサポートするために使用される医療処置です。CRRTは、24時間にわたって継続的に血液を浄化し、電解質バランスを維持しながら老廃物や余分な水分を除去します。CRRTの必要性は、従来の血液透析に耐えられない重症患者に生じ、敗血症や多臓器不全などの病態に不可欠です。CRRTの用途はさまざまな医療環境に及びますが、主に病院、重症治療室、専門クリニックで利用されています。最終用途の範囲には主に集中治療施設を備えた病院が含まれ、医療インフラが改善するにつれて新興諸国での需要が増加する可能性があります。

急性腎不全の発生率の増加、CRRT技術の進歩、糖尿病などの慢性疾患の有病率の上昇が主な市場成長要因です。市場の拡大は、ヘルスケア支出の増加と先進医療に対する政府の取り組みによってさらに促進されます。しかし、運用コストの高さ、熟練者の必要性、感染症などの合併症のリスクが市場成長の課題となっています。費用対効果の高いCRRT装置や医療従事者向けの包括的なトレーニングプログラムを開発することで、より幅広い導入を促し、スキルギャップの問題に対処することができます。

調査と技術革新の分野には、CRRT装置の効率強化、患者の転帰を最適化するためのリアルタイムデータ監視のためのAIの統合、より広い応用のためのポータブルCRRT装置の探求などが含まれます。より効率的な生体適合材料や自動CRRTシステムの研究が進んでおり、市場は大きく成長する態勢にあります。企業にとっては、拡張性のあるテクノロジー・ソリューションに投資し、ヘルスケア・プロバイダーと協力してカスタマイズされたソリューションを提供することで、市場浸透を促進できる可能性があります。ビジネスチャンスが豊富にある一方で、規制遵守を維持し、患者の安全性を重視することは不可欠です。これらの要素を総合すると、CRRT市場は競争的で複雑ではあるが、戦略的イノベーションと適応を通じて成長する道が数多くあることが示唆されます。

市場力学：急速に進化する持続的腎代替療法市場の主要市場インサイトを解明

持続的腎代替療法市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 急性腎障害（AKI）および慢性腎臓病（CKD）の増加
  • 小児および新生児患者向けの改良型CCRTシステムの入手可能性
• 市場抑制要因
  • 持続的腎代替療法手技の高コスト
• 市場機会
  • CRRTの安全性と有効性を高めるための継続的な研究開発
  • CRRT装置および技術に対する政府の好意的な承認
• 市場の課題
  • 持続的腎代替療法に伴う技術的合併症

ポーターの5つの力：持続的腎代替療法市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：持続的腎代替療法市場における外部からの影響の把握

外部マクロ環境要因は、持続的腎代替療法市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析持続的腎代替療法市場における競合情勢の把握

持続的腎代替療法市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス持続的腎代替療法市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、持続的腎代替療法市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 急性腎障害（AKI）と慢性腎臓病（CKD）の発生率の上昇
    • 小児および新生児患者向けの改良されたCCRTシステムの利用可能性
  • 抑制要因
    • 持続的腎代替療法手順のコストが高い
  • 機会
    • CRRTの安全性と有効性を高めるための継続的な研究開発
    • CRRT機器と技術に対する政府の好意的な承認
  • 課題
    • 持続的腎代替療法に関連する技術的な問題
• 市場セグメンテーション分析
  • 製品：急性腎障害（AKI）の罹患率の増加により、シームレスな治療手順のためのCRRTデバイスの必要性が高まっています。
  • 方法：腎臓治療における自由水分管理のための持続静脈血液濾過透析の利用
  • 年齢層：小児集団におけるCRRT要件の違い
  • 適応症：体外腎療法における非腎適応症の採用増加
  • エンドユーザー：患者のニーズに応えるために病院でのCRRT装置の使用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 持続的腎代替療法市場：製品別

• CRRTシステム
• 透析液および補充液
• 使い捨て
  • ボディラインセットとチューブ
  • 血液濾過器

第7章 持続的腎代替療法市場：モダリティ別

• 持続静脈血液濾過透析
• 持続静脈血液透析
• 持続的静脈血液濾過
• 低速連続限外濾過

第8章 持続的腎代替療法市場：年齢層別

• 大人
• 小児科

第9章 持続的腎代替療法市場適応症別

• 非腎臓
• 腎臓

第10章 持続的腎代替療法市場：エンドユーザー別

• 透析クリニック
• ホームケア
• 病院

第11章 南北アメリカの持続的腎代替療法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の持続的腎代替療法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの持続的腎代替療法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • B. BraunがAQUAbase nX逆浸透システムでFDAの認可を取得
  • クアンタ、持続的腎代替療法の適応拡大でFDA 510（k）承認を取得
  • ロックウェル・メディカル、B.ブラウン・メディカルとの3年間の共同プロモーション提携を発表
  • NuwellisとDaVitaが限外濾過療法のパイロットプログラムで提携
  • バクスターとミロマトリックスが肝不全調査で提携
  • PBMC、透析患者向けの新たな腎臓治療オプションを開始
  • シースターメディカルとヌウェリスが腎臓損傷治療で提携
  • Spectral Medical社は、DIMIおよびSAMI透析装置の商業化を加速するためにInfomed社との戦略的合弁事業を発表しました。
  • バクスター、病院での急性腎不全患者の治療に使用されるSTセットの米国FDA承認を発表

企業一覧

• Joline GmbH & Co. KG
• Infomed SA
• Anjue Medical Equipment Co., Ltd.
• Medites Pharma spol. s.r.o
• Baxter International Inc.
• SB-KAWASUMI LABORATORIES, INC.
• Shionogi & Company, Limited
• B. Braun SE
• Medtronic PLC
• Thermo Fisher Scientific Inc.
• Fresenius Medical Care AG & Co. KGaA
• DIAMED Medizintechnik GmbH
• Biomedica Medizinprodukte GmbH
• Nextkidney B.V.
• Asahi Kasei Medical Co., Ltd.
• Nipro Corporation
• Ningbo Tianyi Medical Devices Co., Ltd.
• Braun & Co. Limited
• Quanta Dialysis Technologies Limited
• Miromatrix Medical Inc.
• Sphingotec GmbH
• CytoSorbents Corporation
• Toray Medical Co., Ltd. by Toray Industries, Inc.
• Nuwellis, Inc.
• SWS Hemodialysis Care Co. Ltd.
• Nikkiso Co., Ltd.

LIST OF FIGURES

• FIGURE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET RESEARCH PROCESS
• FIGURE 2. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS
• TABLE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSATES & REPLACEMENT FLUIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY BODYLINE SETS & TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NON-RENAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RENAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 52. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 82. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 83. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 84. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 88. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 89. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 90. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 191. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 192. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 193. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 194. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 215. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 216. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 217. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 218. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 221. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 222. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 223. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 224. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 279. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 280. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

The Continuous Renal Replacement Therapy Market was valued at USD 14.28 billion in 2023, expected to reach USD 15.49 billion in 2024, and is projected to grow at a CAGR of 8.55%, to USD 25.37 billion by 2030.

Continuous Renal Replacement Therapy (CRRT) is a medical procedure used primarily in intensive care units to support patients with acute kidney injury. The procedure continuously purifies the blood over 24 hours, removing waste products and excess fluid while maintaining electrolyte balance. The necessity of CRRT arises in critically ill patients unable to tolerate conventional hemodialysis, making it essential for conditions such as sepsis and multiple organ failures. Its application extends across various medical settings but is predominantly utilized in hospitals, critical care units, and specialty clinics. The end-use scope primarily involves hospitals equipped with intensive care facilities, with potential demand increase in developing countries as medical infrastructures improve.

Growing incidences of acute kidney failure, advances in CRRT technology, and the rising prevalence of chronic conditions like diabetes are key market growth factors. Market expansion is further propelled by increased healthcare spending and government initiatives towards advanced medical procedures. However, high operational costs, the requirement for skilled personnel, and risk of complications such as infections challenge market growth. An opportunity lies in developing cost-effective CRRT machines and comprehensive training programs for healthcare providers, which can encourage wider adoption and address skill gap issues.

Research and innovation areas include enhancing the efficiency of CRRT machines, integrating AI for real-time data monitoring to optimize patient outcomes, and exploring portable CRRT devices for wider application. The market is poised for significant growth with ongoing research into more efficient biocompatible materials and automated CRRT systems. For businesses, investing in scalable technology solutions and collaborating with healthcare providers for customized solutions could enhance market penetration. While opportunities abound, maintaining regulatory compliance and focusing on patient safety are indispensable. These elements collectively suggest that the CRRT market, while competitive and complex, offers numerous avenues for growth through strategic innovation and adaptation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Continuous Renal Replacement Therapy Market

The Continuous Renal Replacement Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of acute kidney injury (AKI) and chronic kidney diseases (CKD)
  • Availability of improved CCRT systems for pediatric and neonatal patients
• Market Restraints
  • High cost of continuous renal replacement therapy procedure
• Market Opportunities
  • Ongoing research and development for enhanced safety and efficacy of CRRT
  • Favorable government approvals for CRRT machines and techniques
• Market Challenges
  • Technical complications associated with continuous renal replacement therapy

Porter's Five Forces: A Strategic Tool for Navigating the Continuous Renal Replacement Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Continuous Renal Replacement Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Continuous Renal Replacement Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Continuous Renal Replacement Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Continuous Renal Replacement Therapy Market

A detailed market share analysis in the Continuous Renal Replacement Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Continuous Renal Replacement Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Continuous Renal Replacement Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Continuous Renal Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include Joline GmbH & Co. KG, Infomed SA, Anjue Medical Equipment Co., Ltd., Medites Pharma spol. s.r.o, Baxter International Inc., SB-KAWASUMI LABORATORIES, INC., Shionogi & Company, Limited, B. Braun SE, Medtronic PLC, Thermo Fisher Scientific Inc., Fresenius Medical Care AG & Co. KGaA, DIAMED Medizintechnik GmbH, Biomedica Medizinprodukte GmbH, Nextkidney B.V., Asahi Kasei Medical Co., Ltd., Nipro Corporation, Ningbo Tianyi Medical Devices Co., Ltd., Braun & Co. Limited, Quanta Dialysis Technologies Limited, Miromatrix Medical Inc., Sphingotec GmbH, CytoSorbents Corporation, Toray Medical Co., Ltd. by Toray Industries, Inc., Nuwellis, Inc., SWS Hemodialysis Care Co. Ltd., and Nikkiso Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Continuous Renal Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across CRRT Systems, Dialysates & Replacement Fluids, and Disposables. The Disposables is further studied across Bodyline sets & tubes and Hemofilters.
• Based on Modality, market is studied across Continuous Venovenous Hemodiafiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemofiltration, and Slow Continuous Ultrafiltration.
• Based on Age Group, market is studied across Adults and Pediatrics.
• Based on Indication, market is studied across Non-renal and Renal.
• Based on End User, market is studied across Dialysis Clinics, Homecare, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of acute kidney injury (AKI) and chronic kidney diseases (CKD)
    • 5.1.1.2. Availability of improved CCRT systems for pediatric and neonatal patients
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of continuous renal replacement therapy procedure
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development for enhanced safety and efficacy of CRRT
    • 5.1.3.2. Favorable government approvals for CRRT machines and techniques
  • 5.1.4. Challenges
    • 5.1.4.1. Technical complications associated with continuous renal replacement therapy
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing prevalence toward acute kidney injury (AKI) boosting a need for CRRT devices for seamless treatment procedures
  • 5.2.2. Modality: Utilization of continuous venovenous hemodiafiltration for liberal fluid management in renal therapies
  • 5.2.3. Age Group: Differing CRRT requirements among pediatric population
  • 5.2.4. Indication: Growing adoption of non-renal indications in extracorporeal renal therapies
  • 5.2.5. End User: Increasing uses of CRRT devices in hospitals to cater a patients need
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Continuous Renal Replacement Therapy Market, by Product

• 6.1. Introduction
• 6.2. CRRT Systems
• 6.3. Dialysates & Replacement Fluids
• 6.4. Disposables
  • 6.4.1. Bodyline sets & tubes
  • 6.4.2. Hemofilters

7. Continuous Renal Replacement Therapy Market, by Modality

• 7.1. Introduction
• 7.2. Continuous Venovenous Hemodiafiltration
• 7.3. Continuous Venovenous Hemodialysis
• 7.4. Continuous Venovenous Hemofiltration
• 7.5. Slow Continuous Ultrafiltration

8. Continuous Renal Replacement Therapy Market, by Age Group

• 8.1. Introduction
• 8.2. Adults
• 8.3. Pediatrics

9. Continuous Renal Replacement Therapy Market, by Indication

• 9.1. Introduction
• 9.2. Non-renal
• 9.3. Renal

10. Continuous Renal Replacement Therapy Market, by End User

• 10.1. Introduction
• 10.2. Dialysis Clinics
• 10.3. Homecare
• 10.4. Hospitals

11. Americas Continuous Renal Replacement Therapy Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Continuous Renal Replacement Therapy Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Renal Replacement Therapy Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. B. Braun Receives FDA Clearance for AQUAbase nX Reverse Osmosis System
  • 14.3.2. Quanta Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies
  • 14.3.3. Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical
  • 14.3.4. Nuwellis, DaVita partner on ultrafiltration therapy pilot program
  • 14.3.5. Baxter, Miromatrix Partner on Liver Failure Research
  • 14.3.6. PBMC Launches New Renal Therapy Option for Dialysis Patients
  • 14.3.7. SeaStar Medical, Nuwellis Partner on Kidney Injury Treatment
  • 14.3.8. Spectral Medical Announces Strategic Joint Venture with Infomed to Accelerate Commercialization of DIMI and SAMI Dialysis Devices.
  • 14.3.9. Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital

Companies Mentioned

• 1. Joline GmbH & Co. KG
• 2. Infomed SA
• 3. Anjue Medical Equipment Co., Ltd.
• 4. Medites Pharma spol. s.r.o
• 5. Baxter International Inc.
• 6. SB-KAWASUMI LABORATORIES, INC.
• 7. Shionogi & Company, Limited
• 8. B. Braun SE
• 9. Medtronic PLC
• 10. Thermo Fisher Scientific Inc.
• 11. Fresenius Medical Care AG & Co. KGaA
• 12. DIAMED Medizintechnik GmbH
• 13. Biomedica Medizinprodukte GmbH
• 14. Nextkidney B.V.
• 15. Asahi Kasei Medical Co., Ltd.
• 16. Nipro Corporation
• 17. Ningbo Tianyi Medical Devices Co., Ltd.
• 18. Braun & Co. Limited
• 19. Quanta Dialysis Technologies Limited
• 20. Miromatrix Medical Inc.
• 21. Sphingotec GmbH
• 22. CytoSorbents Corporation
• 23. Toray Medical Co., Ltd. by Toray Industries, Inc.
• 24. Nuwellis, Inc.
• 25. SWS Hemodialysis Care Co. Ltd.
• 26. Nikkiso Co., Ltd.